A critical appraisal of therapy in rheumatoid arthritis.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000601:surgery / Q000628:therapy*; D001241:Aspirin / Q000627:therapeutic use; D005439:Flufenamic Acid / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D008528:Mefenamic Acid / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D010810:Physical and Rehabilitation Medicine
D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D000963:Antimetabolites; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D006046:Gold; D010653:Phenylbutazone; D001241:Aspirin; D007213:Indomethacin